澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

bridgewest perth pharma pty ltd - lidocaine hydrochloride monohydrate, quantity: 10 mg/ml - injection, solution - excipient ingredients: sodium chloride; water for injections; sodium hydroxide; hydrochloric acid - lignocaine is indicated for the production of local or regional anaesthesia by nerve block, infiltration injection, caudal or other epidural blocks. treatment or prophylaxis of life-threatening ventricular arrhythmias, including those associated with myocardial infarction, general anaesthesia in patients predisposed to ventricular arrhythmias, digitalis intoxication or following resuscitation from cardiac arrest.

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

bridgewest perth pharma pty ltd - lidocaine hydrochloride monohydrate, quantity: 20 mg/ml - injection, solution - excipient ingredients: water for injections; sodium chloride - lignocaine is indicated for the production of local or regional anaesthesia by nerve block, infiltration injection, caudal or other epidural blocks. treatment or prophylaxis of life-threatening ventricular arrhythmias, including those associated with myocardial infarction, general anaesthesia in patients predisposed to ventricular arrhythmias, digitalis intoxication or following resuscitation from cardiac arrest.

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

bridgewest perth pharma pty ltd - lidocaine hydrochloride monohydrate, quantity: 20 mg/ml - injection, solution - excipient ingredients: sodium chloride; water for injections - lignocaine is indicated for the production of local or regional anaesthesia by nerve block, infiltration injection, caudal or other epidural blocks. treatment or prophylaxis of life-threatening ventricular arrhythmias, including those associated with myocardial infarction, general anaesthesia in patients predisposed to ventricular arrhythmias, digitalis intoxication or following resuscitation from cardiac arrest.

新西兰 - 英文 - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - calcium folinate 18.6mg equivalent to folinic acid 15 mg - tablet - 15 mg - active: calcium folinate 18.6mg equivalent to folinic acid 15 mg excipient: lactose monohydrate magnesium stearate microcrystalline cellulose - calcium leucovorin has shown good results in the treatment of certain megaloblastic anaemias resulting from folic acid deficiency. this mainly occurs in infants, during pregnancy, in malabsorption syndromes, liver diseases, sprue and malnutrition. it is not more effective than folic acid for these conditions. calcium leucovorin also has shown good results in reducing the toxicity and circumventing the effect of folic acid antagonists, if therapeutically desired.

爱尔兰 - 英文 - HPRA (Health Products Regulatory Authority)

hospira uk limited - calcium folinate - solution for injection - 7.5 mg/ml - detoxifying agents for antineoplastic treatment

爱尔兰 - 英文 - HPRA (Health Products Regulatory Authority)

hospira uk limited - calcium folinate - solution for injection - 10 mg/ml - detoxifying agents for antineoplastic treatment

爱尔兰 - 英文 - HPRA (Health Products Regulatory Authority)

actavis group ptc ehf - folinic acid - solution for inj/inf - 10 mg/ml - detoxifying agents for antineoplastic treatment

爱尔兰 - 英文 - HPRA (Health Products Regulatory Authority)

teva pharma b.v. - folinic acid - concentrate for solution for infusion - 10 milligram(s)/millilitre - detoxifying agents for antineoplastic treatment; calcium folinate

爱尔兰 - 英文 - HPRA (Health Products Regulatory Authority)

medac gesellschaft fur klinische spezialpraparate - levofolinic acid sodium hydroxide - solution for inj/inf - 50 micromol

爱尔兰 - 英文 - HPRA (Health Products Regulatory Authority)

pharmachemie bv - folinic acid - solution for injection - 25 mg/ml - detoxifying agents for antineoplastic treatment